|
ATE128129T1
(de)
|
1986-07-28 |
1995-10-15 |
American Cyanamid Co |
5(und/oder6) substituierte 2-(2-imidazolin-2- yl)nicotinsäuren, ester und salze, verwendbar als herbizide mittel und zwischenverbindungen für die herstellung dieser nikotinsäuren, ester und salze.
|
|
FR2624698A1
(fr)
|
1987-12-18 |
1989-06-23 |
Bernard Lyon I Universite Clau |
Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-aminomalonyl ou aminosuccinyl amides utiles comme agents edulcorants
|
|
WO1990009787A1
(en)
|
1989-02-27 |
1990-09-07 |
The Du Pont Merck Pharmaceutical Company |
Novel sulfonamides as radiosensitizers
|
|
US5776963A
(en)
|
1989-05-19 |
1998-07-07 |
Hoechst Marion Roussel, Inc. |
3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
|
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
|
JP2807577B2
(ja)
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
|
EP0520573A1
(en)
|
1991-06-27 |
1992-12-30 |
Glaxo Inc. |
Cyclic imide derivatives
|
|
US5389631A
(en)
|
1991-10-29 |
1995-02-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
|
US5364869A
(en)
|
1992-03-09 |
1994-11-15 |
Abbott Laboratories |
Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
|
|
US5326760A
(en)
|
1992-06-29 |
1994-07-05 |
Glaxo, Inc. |
Aminobutanoic acid compounds having metalloprotease inhibiting properties
|
|
JPH06236056A
(ja)
|
1993-02-10 |
1994-08-23 |
Fuji Xerox Co Ltd |
電子写真感光体
|
|
JP3760474B2
(ja)
|
1993-04-22 |
2006-03-29 |
ダイキン工業株式会社 |
電気エネルギーを発生させる方法、装置およびそれに用いるｎ−ｆ結合を有する化合物
|
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
|
DE4343922A1
(de)
|
1993-12-22 |
1995-06-29 |
Basf Ag |
Pyridin-2,3-dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
|
|
KR970007419B1
(ko)
|
1993-12-30 |
1997-05-08 |
한솔제지 주식회사 |
승화형 열전사 기록용 색소
|
|
FR2725946A1
(fr)
|
1994-10-24 |
1996-04-26 |
Lohr Ind |
Cale a rapporter sur un plan porteur presentant des perforations
|
|
US5719144A
(en)
|
1995-02-22 |
1998-02-17 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
DE69628484T2
(de)
|
1995-03-24 |
2004-05-19 |
Takeda Chemical Industries, Ltd. |
Zyklische Verbindungen, ihre Herstellung und ihre Verwendung als Tachykininrezeptorantagonisten
|
|
US5770590A
(en)
|
1995-03-24 |
1998-06-23 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their prudiction and use
|
|
US6166219A
(en)
*
|
1995-12-28 |
2000-12-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
|
DE19608791A1
(de)
|
1996-03-07 |
1997-09-11 |
Hoechst Ag |
Verfahren zur Herstellung von fluorierten Aromaten und fluorierten stickstoffhaltigen Heteroaromaten
|
|
DE19702282C2
(de)
|
1997-01-23 |
1998-11-19 |
Hoechst Ag |
Katalysator für Halex-Reaktionen
|
|
US6177443B1
(en)
|
1997-03-07 |
2001-01-23 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
|
|
EP0973778A1
(en)
|
1997-03-07 |
2000-01-26 |
Novo Nordisk A/S |
4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
|
|
KR19980074060A
(ko)
|
1997-03-21 |
1998-11-05 |
김윤배 |
신규한 치환된 3,4-디알콕시페닐 유도체
|
|
JPH1143489A
(ja)
|
1997-05-30 |
1999-02-16 |
Takeda Chem Ind Ltd |
ヘテロ環化合物、その製造法および剤
|
|
AU751114B2
(en)
|
1998-03-19 |
2002-08-08 |
Takeda Chemical Industries Ltd. |
Heterocyclic compounds, their production and use as tachykinin receptor antagonists
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2000007661A
(ja)
|
1998-06-23 |
2000-01-11 |
Nippon Nohyaku Co Ltd |
複素環ジカルボン酸ジアミド誘導体及びその中間体並びに除草剤
|
|
US6444617B1
(en)
|
1998-07-28 |
2002-09-03 |
Nihon Nohyaku Co., Ltd. |
Fused-heterocycle dicarboxylic acid diamide derivatives or salts thereof, herbicide and usage thereof
|
|
US6348032B1
(en)
*
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
|
EP1145714A4
(en)
|
1998-11-27 |
2004-12-15 |
Takeda Chemical Industries Ltd |
DRUGS
|
|
US6417207B1
(en)
|
1999-05-12 |
2002-07-09 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
HRP20010944B1
(hr)
*
|
1999-06-23 |
2010-08-31 |
Sanofi-Aventis Deutschland Gmbh |
Supstituirani benzimidazoli
|
|
BR0012590A
(pt)
|
1999-07-21 |
2002-04-09 |
Astrazeneca Ab |
Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
|
|
DK1206436T3
(da)
|
1999-08-02 |
2005-02-14 |
Hoffmann La Roche |
Retinoider til behandling af emfysem
|
|
CA2674424C
(en)
|
1999-11-09 |
2012-10-02 |
Abbott Laboratories |
Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
|
|
CA2363274A1
(en)
|
1999-12-27 |
2001-07-05 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs for hepatitis c
|
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
AU2001227757A1
(en)
|
2000-01-12 |
2001-07-24 |
Merck And Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
CN1366518A
(zh)
|
2000-04-25 |
2002-08-28 |
三星电子株式会社 |
作为基质金属蛋白酶抑制剂的联苯基丁酸衍生物
|
|
CA2354606C
(en)
|
2000-08-03 |
2005-12-06 |
Pfizer Products Inc. |
Azabicycloalkane derivatives and therapeutic uses thereof
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
TWI236474B
(en)
|
2001-04-03 |
2005-07-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
|
WO2002081447A1
(en)
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
|
ES2278016T3
(es)
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
|
|
JP3795458B2
(ja)
|
2001-04-19 |
2006-07-12 |
エーザイ株式会社 |
２−イミノピロリジン誘導体
|
|
ES2289116T3
(es)
|
2001-05-24 |
2008-02-01 |
Eli Lilly And Company |
Nuevos derivados de pirrol como agentes farmaceuticos.
|
|
CN1250550C
(zh)
|
2001-07-16 |
2006-04-12 |
盐野义制药株式会社 |
脒衍生物的制备方法
|
|
JP2003171380A
(ja)
|
2001-09-28 |
2003-06-20 |
Takeda Chem Ind Ltd |
三環性化合物の製造法
|
|
WO2003029254A1
(en)
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Process for preparation of tricyclic compounds
|
|
EP1432707B1
(en)
|
2001-10-02 |
2012-03-28 |
Pharmacia & Upjohn Company LLC |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
DE10156719A1
(de)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
Heteroarylcarbonsäureamide
|
|
TWI263640B
(en)
|
2001-12-19 |
2006-10-11 |
Bristol Myers Squibb Co |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
RU2298002C2
(ru)
|
2002-02-04 |
2007-04-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные хинолина в качестве антагонистов npy
|
|
DE10207037A1
(de)
|
2002-02-20 |
2003-08-28 |
Bayer Cropscience Gmbh |
2-Amino-4-bicyclyamino-6H-1,3.5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
AU2003213266A1
(en)
|
2002-03-06 |
2003-09-22 |
Smithkline Beecham Corporation |
Condensed heterocyclic compounds as calcitonin agonists
|
|
WO2003104216A1
(en)
|
2002-06-10 |
2003-12-18 |
Acadia Pharmaceuticals Inc. |
Urotensin ii receptor modulators
|
|
WO2004014365A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Phthalimide derivatives as matrix metalloproteinase inhibitors
|
|
EP1543001B1
(en)
|
2002-09-17 |
2007-08-15 |
Eli Lilly And Company |
Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer
|
|
WO2004044139A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
|
JP2004203791A
(ja)
|
2002-12-25 |
2004-07-22 |
Dai Ichi Seiyaku Co Ltd |
芳香族化合物
|
|
CN1212674C
(zh)
|
2003-01-08 |
2005-07-27 |
东南大学 |
横向缓冲p型金属氧化物半导体管
|
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
GB0308025D0
(en)
|
2003-04-07 |
2003-05-14 |
Glaxo Group Ltd |
Compounds
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
TW200505442A
(en)
|
2003-05-19 |
2005-02-16 |
Genomics Inst Of The Novartis Res Foundation |
Immunosuppressant compounds and compositions
|
|
AU2004240649A1
(en)
|
2003-05-19 |
2004-12-02 |
Irm, Llc |
Immunosuppressant compounds and compositions
|
|
AU2004249664A1
(en)
|
2003-05-19 |
2004-12-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
US20050004133A1
(en)
|
2003-06-05 |
2005-01-06 |
Makings Lewis R. |
Modulators of VR1 receptor
|
|
CN1566099A
(zh)
|
2003-06-13 |
2005-01-19 |
中国科学院上海药物研究所 |
异喹啉－1,3,4－三酮类化合物、制备方法及其用途
|
|
EP1660454A1
(en)
|
2003-07-07 |
2006-05-31 |
Vernalis (R&D) Limited |
Azacyclic compounds as inhibitors of sensory neurone specific channels
|
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
EP1654260A4
(en)
|
2003-08-01 |
2008-09-24 |
Pfizer Prod Inc |
6-LOW HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
|
|
EP1675858A2
(en)
|
2003-09-03 |
2006-07-05 |
Neurogen Corporation |
5-aryl-pyrazolo [4,3-d] pyrimidines, pyridines, and pyrazines and related compounds
|
|
AU2004270713A1
(en)
|
2003-09-05 |
2005-03-17 |
Aventis Pharmaceuticals Inc. |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
|
|
WO2005025504A2
(en)
|
2003-09-12 |
2005-03-24 |
Kemia, Inc. |
Modulators of calcitonin and amylin activity
|
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
|
US7732616B2
(en)
|
2003-11-19 |
2010-06-08 |
Array Biopharma Inc. |
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
|
|
BRPI0416692A
(pt)
|
2003-11-19 |
2007-01-30 |
Array Biopharma Inc |
inibidores heterocìclicos de mek e métodos de emprego destes
|
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
|
JP2007516275A
(ja)
|
2003-12-23 |
2007-06-21 |
ファイザー・プロダクツ・インク |
認知増強および精神病性障害のための治療的組合せ
|
|
JP2007531744A
(ja)
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
６−アザインドール化合物
|
|
WO2005100334A1
(en)
|
2004-04-14 |
2005-10-27 |
Pfizer Products Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
|
DK1809622T3
(da)
|
2004-09-22 |
2010-11-08 |
Janssen Pharmaceutica Nv |
Inhibitorer af interaktionen mellem MDM2 og P53
|
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
|
MX2007008328A
(es)
|
2005-01-07 |
2008-01-16 |
Univ Emory |
Antagonistas cxcr4 para el tratamiento de trastornos medicos.
|
|
DK1848694T3
(da)
|
2005-02-07 |
2010-01-25 |
Hoffmann La Roche |
Heterocykliske substituerede phenylmethanoner som inhibitorer af glycintransporter
|
|
GB0504556D0
(en)
|
2005-03-04 |
2005-04-13 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
DE102005012872A1
(de)
*
|
2005-03-19 |
2006-09-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1877379B1
(en)
|
2005-04-13 |
2013-01-16 |
Astex Therapeutics Limited |
Hydroxybenzamide derivatives and their use as inhibitors of hsp90
|
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
|
WO2007007054A1
(en)
|
2005-07-08 |
2007-01-18 |
Cancer Research Technology Limited |
Phthalamides, succinimides and related compounds and their use as pharmaceuticals
|
|
EP1940819A1
(en)
|
2005-08-16 |
2008-07-09 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 10 inhibitors
|
|
US20090131431A1
(en)
|
2005-09-29 |
2009-05-21 |
Christopher David Edlin |
Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors
|
|
BRPI0618354B8
(pt)
|
2005-11-10 |
2021-05-25 |
Banyu Pharma Co Ltd |
composto e seu uso, composição farmacêutica, preventivo ou remédio
|
|
PE20071241A1
(es)
|
2006-01-17 |
2008-01-14 |
Schering Corp |
Compuestos derivados de hidantoina para el tratamiento de trastornos inflamatorios
|
|
US20080108611A1
(en)
|
2006-01-19 |
2008-05-08 |
Battista Kathleen A |
Substituted thienopyrimidine kinase inhibitors
|
|
US7750034B2
(en)
|
2006-01-25 |
2010-07-06 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
CA2640924C
(en)
|
2006-02-15 |
2013-10-08 |
Merck & Co., Inc. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
EP1999303A4
(en)
|
2006-02-27 |
2010-09-08 |
Univ Leland Stanford Junior |
METHOD FOR IDENTIFYING UPR INHIBITORS
|
|
ATE470665T1
(de)
|
2006-03-22 |
2010-06-15 |
Janssen Pharmaceutica Nv |
Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53
|
|
US7977351B2
(en)
|
2006-03-22 |
2011-07-12 |
Allergan, Inc. |
Heteroaryl dihydroindolones as kinase inhibitors
|
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
CA2653753C
(en)
|
2006-05-16 |
2013-09-24 |
Boehringer Ingelheim International Gmbh |
Substituted prolinamides, production thereof and their use as medicaments
|
|
CN1869036A
(zh)
|
2006-06-30 |
2006-11-29 |
中国药科大学 |
7－取代－3－氯吡咯并[3,4－b]吡啶化合物
|
|
DE102006032824A1
(de)
|
2006-07-14 |
2008-01-17 |
Bayer Healthcare Ag |
Substituierte Indazole
|
|
WO2008010964A1
(en)
|
2006-07-17 |
2008-01-24 |
Merck & Co., Inc. |
1-hydroxy naphthyridine compounds as anti-hiv agents
|
|
EP2051964A4
(en)
|
2006-07-28 |
2012-03-07 |
Univ Connecticut |
INHIBITORS OF FATTY ACID AMIDHYDROLASE
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
WO2008044027A2
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds having hsp90 inhibitory or modulating activity
|
|
US9730912B2
(en)
|
2006-10-12 |
2017-08-15 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
EP2073803B1
(en)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8883790B2
(en)
|
2006-10-12 |
2014-11-11 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8277807B2
(en)
|
2006-10-12 |
2012-10-02 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
AR063311A1
(es)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
EP2101783A2
(en)
|
2006-12-11 |
2009-09-23 |
Novartis Ag |
Method of preventing or treating myocardial ischemia
|
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
|
CA2679563A1
(en)
|
2007-01-08 |
2008-07-17 |
Phenomix Corporation |
Macrocyclic hepatitis c protease inhibitors
|
|
WO2009004496A2
(en)
|
2007-04-13 |
2009-01-08 |
University Of Manitoba |
Bisanthrapyrazoles as anti-cancer agents
|
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
US20100129933A1
(en)
|
2007-04-26 |
2010-05-27 |
Forschungszentrum Karlsruhe Gmbh |
Method for detecting the binding between mdm2 and the proteasome
|
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
|
TW200902533A
(en)
|
2007-05-02 |
2009-01-16 |
Boehringer Ingelheim Int |
Carboxylic acid amides, manufacturing and use thereof as medicaments
|
|
PT2152794E
(pt)
|
2007-05-10 |
2014-05-15 |
Constar Internat Llc |
Moléculas de captura de oxigénio, artigos contendo as mesmas e métodos para a sua utilização
|
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
|
GB0710844D0
(en)
|
2007-06-06 |
2007-07-18 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
|
DE102007034620A1
(de)
|
2007-07-25 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue B1-Antagonisten
|
|
WO2009026248A2
(en)
|
2007-08-17 |
2009-02-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
|
|
IN2012DN05113A
(OSRAM)
|
2007-09-17 |
2015-10-23 |
Abbott Lab |
|
|
US20090076275A1
(en)
|
2007-09-19 |
2009-03-19 |
David Robert Bolin |
Diacylglycerol acyltransferase inhibitors
|
|
US20100210655A1
(en)
|
2007-10-11 |
2010-08-19 |
Yun Ding |
NOVEL sEH INHIBITORS AND THEIR USE
|
|
EP2203412A4
(en)
|
2007-10-16 |
2012-01-11 |
Univ Northeastern |
MONOACYLGLYCEROLLIPASE HEMMER FOR MODULATION OF CANNABINOIDACTIVITY
|
|
JP2011500635A
(ja)
|
2007-10-18 |
2011-01-06 |
ノバルティス アーゲー |
癌および骨疾患の処置のためのｃｓｆ−１ｒ阻害剤
|
|
ES2378185T3
(es)
|
2007-11-29 |
2012-04-09 |
F. Hoffmann-La Roche Ag |
Preparación de derivados de dihidropirrol como productos intermedios
|
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
|
ATE531711T1
(de)
*
|
2007-12-18 |
2011-11-15 |
Arena Pharm Inc |
Für die behandlung von autoimmunerkrankungen und entzündlichen erkrankungen geeignete tetrahydrocyclopentaäbüindol-3- ylcarbonsäurederivate
|
|
EP2078711A1
(en)
|
2007-12-28 |
2009-07-15 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. |
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
|
|
GB0800035D0
(en)
*
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
CN101225070B
(zh)
|
2008-01-31 |
2010-04-14 |
上海交通大学 |
用于抗肿瘤的药物
|
|
HRP20130160T1
(hr)
|
2008-02-05 |
2013-03-31 |
Sanofi |
Derivati sf5 kao inhibitori par1, njihovo dobivanje, te upotreba kao medikamenata
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
GB0804702D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
|
GB0809776D0
(en)
|
2008-05-29 |
2008-07-09 |
Amura Therapeutics Ltd |
Compounds
|
|
CA2727252A1
(en)
|
2008-07-01 |
2010-01-07 |
Genentech, Inc. |
Isoindolone derivatives as mek kinase inhibitors and methods of use
|
|
ES2612731T3
(es)
|
2008-08-19 |
2017-05-18 |
Janssen Pharmaceutica Nv |
Antagonistas de receptores al frío de mentol
|
|
WO2010024258A1
(ja)
|
2008-08-29 |
2010-03-04 |
塩野義製薬株式会社 |
Ｐｉ３ｋ阻害活性を有する縮環アゾール誘導体
|
|
EP2334183A4
(en)
|
2008-09-16 |
2012-06-06 |
Merck Sharp & Dohme |
METABOTROPE GLUTAMATE R4 LIGANDS FROM SULFONAMIDE
|
|
US20100125081A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 574
|
|
WO2010056195A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 575
|
|
CN101455661B
(zh)
|
2008-11-19 |
2012-10-10 |
中国科学院上海有机化学研究所 |
3-取代苯酞及其类似物的用途
|
|
MX2011006108A
(es)
|
2008-12-08 |
2011-11-18 |
Vm Pharma Llc |
Composiciones de inhibidores de los receptores tirosina quinasa.
|
|
CN102300852B
(zh)
|
2009-01-28 |
2015-04-22 |
拜尔农科股份公司 |
杀真菌剂 n-环烷基-n-双环亚甲基-羧酰胺衍生物
|
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
|
CN102770431A
(zh)
*
|
2009-12-23 |
2012-11-07 |
赛诺菲 |
[4[4-(5-氨基甲基-2-氟-苯基)-哌啶-1-基]-(1h-吡咯并吡啶-基)-甲酮及其合成
|
|
WO2011090473A1
(en)
|
2010-01-19 |
2011-07-28 |
Frank Ivy Carroll |
Kappa opioid receptor binding ligands
|
|
KR20120117905A
(ko)
|
2010-01-28 |
2012-10-24 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
프로테아좀 활성을 향상시키는 조성물 및 방법
|
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
EP2571876B1
(en)
|
2010-05-21 |
2016-09-07 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
WO2012028100A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
WO2012027965A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
AU2011295725B2
(en)
|
2010-09-03 |
2015-03-26 |
Forma Tm, Llc. |
Novel compounds and compositions for the inhibition of NAMPT
|
|
US9266855B2
(en)
|
2010-09-27 |
2016-02-23 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
JP2013253019A
(ja)
|
2010-09-28 |
2013-12-19 |
Kowa Co |
新規なピペリジン誘導体及びこれを含有する医薬
|
|
US9512111B2
(en)
|
2010-11-08 |
2016-12-06 |
Lycera Corporation |
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
|
MX2013005008A
(es)
|
2010-11-10 |
2013-08-01 |
Gruenenthal Gmbh |
Derivados de carboxamida y urea heteroaromaticos sustituidos como ligandos del receptor vanilloide.
|
|
WO2012100732A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
|
|
WO2012100734A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Compounds useful as retinoid-related orphan receptor gamma modulators
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
CN102180780A
(zh)
|
2011-03-07 |
2011-09-14 |
中国科学技术大学 |
茚酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途
|
|
CA2829123C
(en)
|
2011-03-14 |
2016-04-12 |
Eternity Bioscience Inc. |
Quinazolinediones and their use
|
|
WO2012134943A1
(en)
|
2011-03-25 |
2012-10-04 |
Abbott Laboratories |
Trpv1 antagonists
|
|
US9469667B2
(en)
|
2011-04-04 |
2016-10-18 |
Merck Patent Gmbh |
Metal complexes
|
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
TWI532728B
(zh)
|
2011-04-28 |
2016-05-11 |
日本煙草產業股份有限公司 |
醯胺化合物及其醫藥用途
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
EP2736330A4
(en)
*
|
2011-07-29 |
2015-05-27 |
Tempero Pharmaceuticals Inc |
COMPOUNDS AND METHODS
|
|
WO2013019635A1
(en)
|
2011-07-29 |
2013-02-07 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
EP2736332A4
(en)
|
2011-07-29 |
2015-03-18 |
Tempero Pharmaceuticals Inc |
CONNECTIONS AND METHODS
|
|
EP2738170B1
(en)
|
2011-07-29 |
2017-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
EP2736329A4
(en)
|
2011-07-29 |
2015-03-25 |
Tempero Pharmaceuticals Inc |
COMPOUNDS AND METHODS
|
|
WO2013029338A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel compounds
|
|
WO2013042782A1
(ja)
|
2011-09-22 |
2013-03-28 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
|
US20140256767A1
(en)
|
2011-10-31 |
2014-09-11 |
The Broad Institute, Inc. |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
|
WO2013078240A1
(en)
*
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-biphenylmethylbenzimidazole modulators of pparg
|
|
WO2013078233A1
(en)
*
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-benzylbenzimidazole modulators of pparg
|
|
CA2856946C
(en)
|
2011-12-02 |
2016-08-02 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases
|
|
US8741892B2
(en)
|
2011-12-05 |
2014-06-03 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
US8642774B2
(en)
|
2011-12-08 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
US8796467B2
(en)
|
2011-12-13 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
WO2013092460A1
(en)
|
2011-12-20 |
2013-06-27 |
Syngenta Participations Ag |
Cyclic bisoxime microbicides
|
|
AU2012358978B2
(en)
|
2011-12-21 |
2017-10-05 |
Allergan, Inc. |
Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
|
|
US20130190356A1
(en)
|
2011-12-22 |
2013-07-25 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as rorc modulators
|
|
US9216988B2
(en)
|
2011-12-22 |
2015-12-22 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as RORc modulators
|
|
WO2013100027A1
(ja)
|
2011-12-28 |
2013-07-04 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2013159095A1
(en)
|
2012-04-20 |
2013-10-24 |
Anderson Gaweco |
Ror modulators and their uses
|
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
|
TWI593678B
(zh)
|
2012-04-27 |
2017-08-01 |
葛蘭素集團有限公司 |
作為類視色素相關孤兒受體γ(RORγ)調節劑之化合物、其醫藥組合物及用途
|
|
EP2844259A4
(en)
|
2012-04-30 |
2015-11-11 |
Anderson Gaweco |
MMR MODULATORS AND USES THEREOF
|
|
WO2013169704A2
(en)
|
2012-05-08 |
2013-11-14 |
Merck Sharp & Dohme Corp. |
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
|
IN2014DN08025A
(OSRAM)
|
2012-05-08 |
2015-05-01 |
Merck Sharp & Dohme |
|
|
AU2013259624B2
(en)
|
2012-05-08 |
2017-10-19 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease
|
|
CN104603118B
(zh)
|
2012-05-31 |
2017-10-03 |
菲尼克斯药品股份公司 |
作为孤儿核受体RORγ调节物的经甲酰胺或磺酰胺取代的噻唑及相关衍生物
|
|
WO2014008214A1
(en)
|
2012-07-02 |
2014-01-09 |
Biogen Idec Ma Inc. |
Biaryl-containing compounds as inverse agonists of ror-gamma receptors
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
WO2014044738A1
(en)
|
2012-09-21 |
2014-03-27 |
Sanofi |
Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
|
|
US9309222B2
(en)
*
|
2012-10-16 |
2016-04-12 |
Janssen Pharmaceutica Nv |
Phenyl linked quinolinyl modulators of RORγt
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
CN105121430B
(zh)
|
2012-12-06 |
2017-06-16 |
葛兰素集团有限公司 |
用于治疗自身免疫性和炎性疾病的类维生素A相关的孤儿受体γ(RORγ)的调节剂
|
|
WO2013171729A2
(en)
|
2013-01-08 |
2013-11-21 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl amide compounds as rorgamat modulator
|
|
US9868748B2
(en)
|
2013-05-01 |
2018-01-16 |
Vitae Pharmaceuticals, Inc. |
Thiazolopyrrolidine inhibitors of ROR- γ
|
|
TWI652014B
(zh)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
雜環取代之雙環唑殺蟲劑
|
|
CN105829295A
(zh)
*
|
2013-10-15 |
2016-08-03 |
詹森药业有限公司 |
与苯基连接的Rorγt喹啉基调节剂
|
|
WO2015083130A1
(en)
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
|
PE20161405A1
(es)
|
2013-12-24 |
2017-01-18 |
Harvard College |
Analogos de cortistatina y sintesis y usos de los mismos
|
|
JP2015124178A
(ja)
|
2013-12-26 |
2015-07-06 |
東レ株式会社 |
環状アミン誘導体及びその医薬用途
|
|
WO2015101928A1
(en)
|
2013-12-31 |
2015-07-09 |
Aurigene Discovery Technologies Limited |
Fused thiophene and thiazole derivatives as ror gamma modulators
|
|
CR20160402A
(es)
|
2014-02-03 |
2017-02-07 |
Basf Se |
Compuesto de ciclopenteno y ciclopentadieno para controlar plagas de invertebrados
|
|
UA121309C2
(uk)
|
2014-02-03 |
2020-05-12 |
Вітае Фармасьютікалс, Ллс |
Дигідропіролопіридинові інгібітори ror-гамма
|
|
WO2015139619A1
(zh)
*
|
2014-03-18 |
2015-09-24 |
北京韩美药品有限公司 |
作为RORγ调节剂的化合物
|
|
EA037928B1
(ru)
|
2014-03-26 |
2021-06-08 |
Ф. Хоффманн-Ля Рош Аг |
Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
|
|
MX2016012540A
(es)
|
2014-03-26 |
2017-01-09 |
Basf Se |
Compuestos de [1,2,4]triazol e imidazol sustituidos, como fungicidas.
|
|
JP6554481B2
(ja)
|
2014-03-26 |
2019-07-31 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
オートタキシン（ａｔｘ）及びリゾホスファチジン酸（ｌｐａ）産生の阻害剤としての縮合［１，４］ジアゼピン化合物
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
WO2015145371A1
(en)
*
|
2014-03-27 |
2015-10-01 |
Piramal Enterprises Limited |
Ror-gamma modulators and uses thereof
|
|
SG11201607518RA
(en)
*
|
2014-04-16 |
2016-10-28 |
Glenmark Pharmaceuticals Sa |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
|
BR112017007460A2
(pt)
|
2014-10-14 |
2017-12-19 |
Vitae Pharmaceuticals Inc |
inibidores de di-hidropirrolopiridina de ror-gama
|
|
EP3209299A4
(en)
|
2014-10-22 |
2018-04-04 |
The Board of Regents of The University of Texas System |
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
|
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
US9845308B2
(en)
|
2014-11-05 |
2017-12-19 |
Vitae Pharmaceuticals, Inc. |
Isoindoline inhibitors of ROR-gamma
|
|
CN112679467B
(zh)
|
2015-03-11 |
2024-11-01 |
Fmc公司 |
杂环取代的二环唑杀有害生物剂
|
|
ES2856931T3
(es)
|
2015-08-05 |
2021-09-28 |
Vitae Pharmaceuticals Llc |
Moduladores de ROR-gamma
|
|
MX385332B
(es)
|
2015-11-20 |
2025-03-18 |
Vitae Pharmaceuticals Llc |
Moduladores de ror-gamma.
|
|
TW202220968A
(zh)
|
2016-01-29 |
2022-06-01 |
美商維它藥物有限責任公司 |
ＲＯＲ－γ調節劑
|
|
US9481674B1
(en)
|
2016-06-10 |
2016-11-01 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|